Group 1: Offshore Engineering Outlook - As of June 2025, the offshore engineering segment holds approximately $5.55 billion in orders, scheduled for production until 2027/2028 [2][3] - The company focuses on high-quality, high-end equipment orders, primarily in oil and gas projects like FPSO/FLNG [3] - Economic uncertainties and high interest rates have delayed some projects, but industry forecasts predict a release of delayed projects in 2026, with continued investment peaks through 2028 [3] Group 2: Competitive Advantages - The company boasts a strong design capability with nearly 4,000 employees, including a dedicated R&D team of about 1,200, and four research centers located in China and Europe [4] - A one-stop delivery capability is established through a robust manufacturing and supply chain system, enhancing efficiency in modular construction and cost control [4][5] - A highly responsive global supply chain allows for real-time data sharing with clients, ensuring transparency and collaboration throughout the construction process [5][6] Group 3: Container Manufacturing and Storage Business - Long-term confidence in container manufacturing is based on the correlation with global trade volume, which is expected to grow due to population increase and wealth elevation [7] - The storage business has become a key growth area, with a cumulative shipment of over 60 GWh of storage equipment, positioning the company as a global leader [8] Group 4: Data Center Innovations - The company has developed a modular data center project in Malaysia, featuring 833 modules and a total IT load of approximately 60 MW, completed in under 10 months [9][10] - Innovative cooling solutions and modular designs enhance construction speed and energy efficiency, showcasing the company's leadership in industrialized data center solutions [10]

Group 1: Company Overview and Strategy - The company focuses on integrating resources in channels and supply chains to enhance production and sales efficiency [2] - Emphasis on developing a cross-border sales network to increase overseas market penetration [2] - Aiming to establish a closed-loop supply chain for new business expansion by optimizing upstream raw material supply and downstream production processes [2] Group 2: B-end Market Development - The company employs a scenario-driven and technology-enabled approach to target B-end customers [3] - Leading in the safety protection and flexible connection sectors, offering a full range of products from core materials to end products [3] - Plans to enhance organizational capabilities and marketing team effectiveness to support B-end market growth [3] Group 3: C-end Market Growth - Growth in the C-end market will be driven by product, operation, and technology collaboration, with a focus on brand strength [4] - Investment in R&D for core products to create differentiated competitive advantages while optimizing cost structures [4] - Utilizing AI and algorithms to improve customer acquisition efficiency and reduce costs [4] Group 4: Cross-border Channel Expansion - Significant growth potential in cross-border channels, with plans to expand sales of new categories on platforms like Amazon and TikTok [4] - Strategy includes leveraging existing market resources to enhance overall cross-border business capabilities [4] Group 5: Market Strategy and Profitability - The company adopts a focused and differentiated market strategy, prioritizing high-barrier core categories and avoiding homogeneous competition [5] - Plans to optimize revenue structure by expanding high-margin B-end and overseas markets while improving operational efficiency in traditional C-end business [5] - Aiming to enhance profitability through AI-driven cost optimization and inventory management [5]

Group 1: Company Performance and Market Dynamics - The company's revenue from functional shoe materials and sofa home products accounted for nearly 70% of total revenue by the end of Q3 2025, while automotive interiors and electronics contributed about 30% [3] - The automotive interior segment has shown significant growth due to increased collaborations with automotive brands and specific projects, leading to a rise in revenue share [3] - The company operates in a highly customized industry where order visibility is relatively low due to various market dynamics and customer strategies [2] Group 2: Industry Insights and Competitive Landscape - The synthetic leather market in China is approximately ¥90 billion, with PU synthetic leather representing about 40% of this market [4] - The industry is characterized by low concentration, with many players, but the company has a market share exceeding 20% in certain mid-to-high-end segments [5] - Stricter environmental regulations are leading to the elimination of non-compliant companies, resulting in a clearer industry differentiation [5] Group 3: Product Development and Innovation - The company is actively developing bio-based and recycled materials, although their current revenue contribution is small [8] - The core competitive advantage lies in over 30 years of expertise in polyurethane composite materials, focusing on high-performance and eco-friendly solutions [9] - The company has established strong customer relationships, which are difficult for competitors to replicate due to long certification processes and ongoing evaluations [9] Group 4: Future Growth Strategies - The company plans to expand its market share in the automotive interior segment while balancing resources across various product categories [3] - Future growth in the consumer electronics segment will focus on acquiring new clients and exploring new application scenarios [7] - The company is considering mergers and acquisitions as part of its strategy to deepen its core business and expand related applications, with plans to disclose any developments in accordance with regulations [10]

Group 1: Company Overview - The company specializes in consumer products, including PCBA (e.g., nebulizer controllers) and finished consumer goods (e.g., small appliances) [2] - The revenue from nebulizer controllers has declined, while income from small appliances and home electronics has increased [2] Group 2: Product and Market Insights - The company is optimistic about the consumer segment for the upcoming year due to new product introductions and gradual mass production [2] - In the robotics sector, the company focuses on pool cleaning robots, collaborating with clients such as UBTECH and StarMaker Innovation [3] Group 3: Storage Business and Competitive Edge - The core market for the company's energy storage products is in Africa, specifically in countries like Nigeria, Kenya, and Tanzania, targeting off-grid household electricity needs [3] - The company's competitive advantage lies in manufacturing processes and strong cost control capabilities [3] Group 4: Challenges and Strategic Responses - The company faces challenges including rising management costs due to factory relocations and new factory construction in Thailand, as well as pressure on average selling prices affecting gross margins [3] - Strategies to address these challenges include enhancing automation, optimizing production layout, and increasing the proportion of high-value-added products [3] Group 5: Future Plans and Financial Strategy - The company is actively seeking investment opportunities that align with its upstream and downstream operations, prioritizing firms with strong technology, brand influence, or established sales channels [3] - The increase in bank credit limit for 2026 is aimed at supporting potential external investments or asset acquisition plans [3] Group 6: Disclosure Information - The activity did not involve any undisclosed significant information [3]

Group 1: Automotive Business Overview - The company focuses on the development, production, and sales of high-strength precision fasteners and special connectors, primarily used in automotive engine turbocharging systems, transmission control systems, exhaust systems, and key components of vehicles [2][3] - In the new energy vehicle sector, products are applied in battery trays, chassis, body, electronic control inverters, and battery swapping systems [3] Group 2: Commercial Aerospace Business Overview - The commercial aerospace sector includes manufacturing rocket structural components, such as body segments, fairings, fuel tanks, and engine valves, with production lines completed in 2024 [3] - The company has established a strong customer base among leading private rocket companies in China [3] Group 3: Competitive Landscape and Capacity Planning - The supply of rocket structural components is a bottleneck in the commercial aerospace sector, with a favorable competitive landscape [3] - The company has a production capacity of 10 rockets per year, with the ability to increase capacity based on order demand, requiring approximately four months for expansion [3] Group 4: Revenue Growth Drivers in Automotive Business - Key drivers for revenue growth include expansion in automotive parts exports, with a focus on overseas markets and strong relationships with major international suppliers [4] - Domestic growth is supported by new customer development, product category expansion, industry consolidation, and localization [4] Group 5: Profitability and Margin Trends - The automotive business has experienced a decline in gross margin due to factors such as a slowdown in industry growth, rising material costs since late 2021, and increased depreciation from new projects [4] - The company anticipates a recovery in profitability as new factory capacities are released, with expectations for improved margins in the future [4] Group 6: Information Disclosure and Communication - The company adheres to strict information disclosure management practices, ensuring transparency and accuracy in communications with investors [5]

Group 1: Company Overview - The company focuses on anti-corrosion and wear-resistant welding equipment, continuously expanding into industrial equipment manufacturing and high-end structural components [1] - Key technologies include material, process, and equipment, with certifications such as the National Special Equipment Production License and ASME certification [1] - The management team has extensive industry experience and a stable core technical staff, enhancing the company's competitive edge [1] Group 2: Market Opportunities - The waste incineration market is expanding, driven by urbanization in developing countries, with countries like Vietnam and Thailand prioritizing waste-to-energy solutions [3][4] - The coal-fired power generation sector shows significant growth potential, with increasing demand for upgrades in developed regions [2] - The company has strategically positioned itself in HRSG and composite pipe businesses, with HRSG already achieving substantial production capacity [2] Group 3: International Expansion - As of September 30, 2025, overseas revenue reached approximately 200 million, accounting for about 54.28% of total revenue, with exports primarily to Asia, the US, South America, and Europe [5] - The company has established a factory in Vietnam, which has commenced operations, and is expanding into the Middle East oil and gas pipeline market [2] Group 4: Competitive Landscape - In the Vietnamese market, competitors include manufacturers from South Korea, Thailand, and Vietnam, but the company holds advantages in production costs and established customer relationships [6][8] - The company plans to expand its HRSG production lines in Vietnam from 4 to a total of 12, depending on market demand [8] Group 5: Pricing and Future Outlook - HRSG pricing is determined by material and labor costs, with adjustments based on market demand and production capacity [9] - The global oil and gas pipeline market is expected to grow due to increasing natural gas demand and the need for infrastructure upgrades, with the company adapting its production strategy to align with market needs [9]

Group 1: Company Development Strategy - The company has been developing along two parallel paths since its listing: expanding its existing main business and exploring new growth opportunities [2] - The main business will focus on the research, production, and sales of bottle caps for the beverage and food packaging sectors, with plans to diversify into other packaging products for personal care, medical, and health products [2] - The company aims for external growth through strategic acquisitions, particularly in light of supportive acquisition policies announced in September 2024 [3] Group 2: Financial Health and Risk Management - The company has a low asset-liability ratio and has maintained steady profitability and cash flow over the years, indicating strong financial health [3] - There is a clear emphasis on risk management, with the company providing adequate risk warnings regarding ongoing acquisition plans, ensuring compliance with information disclosure regulations [3]

Group 1: Investor Relations Activity - The investor relations activity involved a meeting with analysts from Morgan Fund Management, Guolian Minsheng Securities, and Shenzhen Yide Global Fund Management on December 8, 2025 [1] - The meeting was held in the company conference room and included discussions on the company's new drug inclusion in the national medical insurance directory [1] Group 2: New Drug Inclusion - The innovative drug, Olanavir Tablets (brand name: Anruiwei®), was included in the National Medical Insurance Directory on December 7, 2025, following negotiations with the National Healthcare Security Administration [1][3] - Other core products such as Liraglutide Tablets and various capsules were also included in this directory, enhancing their market accessibility [1] Group 3: Drug Characteristics - Olanavir Tablets are the world's first oral drug targeting the PB2 subunit of the RNA polymerase of the influenza A virus, approved for adult patients with uncomplicated influenza [3][4] - The drug demonstrates rapid symptom relief, strong antiviral effects, and low resistance rates, with positive results from clinical trials [4][5] Group 4: Sales and Marketing Strategy - The company plans to enhance marketing through three dimensions: building an academic ecosystem, upgrading data services, and implementing key project practices [8] - The inclusion of Olanavir Tablets in the National Medical Insurance Directory is expected to positively impact market promotion and long-term business development [8] Group 5: Pediatric Development Plans - The company is developing Olanavir Granules for children and adolescents, with ongoing Phase III clinical trials for both adolescents (ages 12-17) and children (ages 2-11) [9][11] - The trials aim to establish a comprehensive treatment matrix for influenza across all age groups [11] Group 6: Other Drug Developments - RAY1225 injection, an innovative dual-agonist drug for type 2 diabetes and obesity, has shown positive results in Phase II clinical trials and is progressing to Phase III trials [12][13] - ZSP1601 tablets, targeting metabolic dysfunction-related fatty liver disease, have completed early clinical trials with promising results and are moving into Phase IIb trials [15][16] Group 7: Research and Development Pipeline - The company is focusing on innovative drug development in respiratory and metabolic diseases, with projects targeting unmet clinical needs [16][18] - Ongoing research includes a new drug for respiratory syncytial virus (RSV) and various GLP-1 receptor agonists, with clinical candidates identified and preclinical studies underway [16][18]

问 3：请介绍公司未来除了将在手能源指标资产化项目化， 是否还有对外并购规划。 证券代码：002480 证券简称：新筑股份 成都市新筑路桥机械股份有限公司 投资者关系活动记录表 编号：2025-007 投 资 者关 系 活 动类别 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 （请文字说明其他活动内容） 活动参与人员 公司参与人员：董事会秘书陈思遥、首席合规官贾珺； 四川蜀道清洁能源集团有限公司：总工程师孙周； 参与机构：国新控股（四川）有限公司、国新盛康私募基金管 理（北京）有限公司 时间 2025 年 12 月 4 日（星期四）下午 3:00-5:00 地点 蜀道清洁能源集团 240 会议室 形式 现场交流 交 流 内容 及 具 体问答记录 一、基本情况介绍 成都市新筑路桥机械股份有限公司（以下简称"新筑股份 或公司"）副总经理、董事会秘书陈思遥简要介绍了公司历史 沿革、产业现状和本次重组背景，同时介绍了控股股东蜀道集 团三大主业板块（含清洁能源板块）、发展规划和产业协同。 二、问答环节 问 1：新筑股份本次重大资产重组完成后，对公司营收 ...

Group 1: Company Overview and Strategy - Hunan Jiutian Pharmaceutical Co., Ltd. is focusing on expanding its market presence through a multi-channel strategy and brand enhancement initiatives, including the launch of the "Jiutian Zhen Tong Xian Sheng" branding campaign on December 6, 2025 [2][3] - The company aims to strengthen its product pipeline by increasing R&D investments and introducing new products, while also leveraging its integrated supply chain to control costs and ensure product quality [3][4] Group 2: Product Specifics and Market Response - The company’s key product, Loxoprofen Sodium Gel Patch, has been selected in the 11th round of national drug centralized procurement at prices of ¥17.88 for 4 patches, ¥26.82 for 6 patches, and ¥35.76 for 8 patches, with a total planned selection of approximately 30.12 million patches [5] - Following the price reduction from centralized procurement, the company anticipates a potential increase in sales volume for Loxoprofen Sodium Gel Patch, contingent on market conditions post-implementation [5] Group 3: Mergers and Acquisitions - The company has acquired a 67% stake in Hunan Nona Pharmaceutical Technology Co., Ltd., which includes 67 drug licenses, enhancing its product offerings and market stability [3][4] - This acquisition is expected to fill potential sales gaps from the centralized procurement of Loxoprofen Sodium Gel Patch and diversify the product range with unique offerings like the Daiwen Moxibustion Patch [3] Group 4: Innovation and R&D Focus - The company is transitioning towards innovative drug development, establishing multiple R&D centers and focusing on various drug forms and cooperative models to expedite the development of new drugs [4][6] - Current R&D efforts are concentrated on oncology and chronic disease treatments, utilizing small molecules, peptides, and other advanced drug forms to build a robust pipeline [4][6] Group 5: Future Product Development - The JIJ02 gel is expected to complete Phase I clinical trials in the first half of 2026, with plans to initiate Phase II trials thereafter [7] - The company is optimistic about the market prospects for Ketoprofen Gel, which was approved in 2023 and included in the national medical insurance directory, and is implementing new sales strategies to enhance market penetration [7]